What our customers say

"Sciomics….a perfect solution for antibody based arrays"

Dr. Bhavani KowtharapuRostock University Medical Center, Department of Ophthalmology, Rostock, Germany "I am really happy…

"I can say they delivered on every level"

Abigail Martin, PhD University of Hertfordshire, Hertfordshire, United Kingdom "Sciomics offered a professional and efficient …

"Sciomics offers excellent service and advice. I'm very satisfied."

Dr. Clarissa von Haefen Charité University Clinics, Berlin, Germany "Ich fühle mich sehr gut beraten…

"We absolutely recommend Sciomics to everyone interested in an antibody array service"

Prof. Dr. Markus GrälerUniversity Hospital Jena, SG Sepsis Research, Department of Anaesthesiology and Intensive Care…

"Sciomics Antibody Microarray really helped us to move forward"

José Pedro Castro, PhD German Instiute of Human Nutrition (DIfE), Potsdam-Rehbrücke, Germany "I am more…

"The most professional service you can expect"

Yaroslav Shcherba University Lausanne, Institut de Biotechnologie, Lausanne, Switzerland "The custom microarray slides produced by…

"Sciomics service was more than satisfactory"

Reece Marillier, PhD Ludwig Institute for Cancer Research, Brussels, Belgium "... In addition Sciomics gave…

"Comprehensive and precise results of great interest for our prospective work"

Dr. Renate Keßler Institute of Biochemistry, Medical Faculty, University of Leipzig, Germany "For our work…

"A partner who pays attention to the smallest details"

Gaith Bakdash, PhD Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, RadboudUMC, Nijmegen,…

"This has undoubtedly opened new avenues in our research"

Leonardo Guasti, PhD Barts and The London, Queen Mary's School of Medicine and Dentistry, London,…

"Impressive protein profiling service and great communication"

Dr. Andreas Vogt Assay Development, Bioassay - Labor für biologische Analytik GmbH, Heidelberg, Germany "For…

"Wir haben unser Ziel zu vollkommener Zufriedenheit erreichen können"

Prof. Dr. Matthias Gorenflo Universitätsklinikum Heidelberg, Zentrum für Kinder- und Jugendmedizin, Pädiatrische Kardiologie & Angeborene…

Vote for your favourite PTM

We would like to develop exactly what you need for your research projects and bring innovation directly to your lab. Therefore, your feedback is greatly appreciated.

Please click below to vote for your favourite Post-Translational Modification to be included in our platform

 


Acetylation
    
Glycosylation

 


Methylation
    
Phosphorylation

 


SUMOylation
    
Ubiquitinylation

 


Contact us

 

 

My favourite PTM is Acetylation

Thank you for ranking Acetylation as your favourite PTM to be integrated in our platform.

 

 Do you have questions about this assay and how it can support your research projects ?

Are you interested to participate in the final development stages ?

 

 Contact us anytime for further information or to discuss your project - This email address is being protected from spambots. You need JavaScript enabled to view it.

 

 Newsletter:   Register for our newsletter to receive updates on the results of this survey and the availability of our novel PTM analysis services.

 

 Already available: scioPhospho for protein + phosphorylation profiling

 Would you like to learn more about our scioPhospho assay to analyse protein levels and phosphorylation status in parallel ?

 

 

 

scioPhospho: parallel protein and phosphorylation profiling
scioPhospho: Eight treated cell line samples were compared with 8 control samples. Several proteins were identified as differentially expressed (x-axis) and/or phosphorylated (y-axis). While the left plot provides an overview on expression / phosphorylation differences for all tested proteins in the two sample groups, individual levels are depicted in the plots on the right. The sample status is indicated as C = control or T = treated.

Products & Services

scioDiscover - Protein Expression Analysis

scioDiscover - Protein Expression Analysis

Our scioDiscover service enables high-content, immuno-based analysis of various biological samples leading to a comprehensive overview of proteomic changes. Key pathways in various diseases such as cancer, neurological disorders and organ failure are covered. The technology was successfully applied in a variety of biomedical studies and to discover new biomarker…
Read more
scioDiscover - Protein Expression Level Profiling

scioDiscover - Protein Expression Level Profiling

Knowledge about protein expression levels is of utmost importance to predict toxic effects, estimate adverse effects of drug candidates and to identify new drug targets. Sciomics has a highly optimised range of protein profiling services available. These help you to speed up your research and generate important data at lower…
Read more
scioPhospho: protein + phosphorylation profiling

scioPhospho: protein + phosphorylation profiling

scioPhospho combines the advantages of a robust and cost-efficient protein expression profiling using scioDiscover with information on phosphorylation status. This combination provides a comprehensive overview on signalling events and pathway…
scioCD - Cell surface marker and Cytokine profiling

scioCD - Cell surface marker and Cytokine profiling

Characterise a certain cell type ? Cell composition in a certain tissue sample ? In-depth profiling of CD-marker expression ? Increase your throughput at high sensitivity levels ? You aim…
scioDiscover - Protein Biomarker Discovery

scioDiscover - Protein Biomarker Discovery

Personalised Medicine and Diagnostic Research require techniques to discover and verify novel and more accurate Biomarkers. We offer a comprehensive immuno-based Protein Biomarker Discovery Service using complex Antibody Microarrays. This…
scioSpec - Antibody Specificity Assessment

scioSpec - Antibody Specificity Assessment

Be sure that your antibody is fit for your application. Profile your therapeutic or diagnostic antibody against more than 9000 human proteins. Have a comprehensive cross-reactivity and off-target reactivity profile…
scioExtract - Protein Extraction Buffers

scioExtract - Protein Extraction Buffers

The Scio-Extract Protein Extraction Buffers are optimised for superior protein isolation performance from all cell compartments and of membrane proteins. Their non-denaturing properties enable the extraction of active proteins under…
scioSpot - Custom Antibody Microarrays

scioSpot - Custom Antibody Microarrays

Antibody Microarrays - tailor-made for you. With more than 10 years of experience, Sciomics is the ideal partner for designing and printing your antibody chips as well as arrays of…
scioSpot - Microarray Production

scioSpot - Microarray Production

Microarrays - tailor-made for you. With more than 10 years of experience, Sciomics is the ideal partner for designing and printing your antibody-, protein-, peptide- or DNA/RNA chips. Benefit from…

News

New article | Expansion of a BDCA1+CD14+ Myeloid Cell Population in Melanoma Patients May Attenuate the Efficacy of Dendritic Cell Vaccines.

| July 2016 | One of our customer projects was published in Cancer Research. In this study Bakdash et al. analysed the expansion of a BDCA1+CD14+ myeloid cell population in the context of immune therapy of melanoma. Within this study a protein profiling of cellular patient samples was performed with scioCD antibody arrays.

Interview | Advanced Biomarkers for Precision Medicine

New article | Analysis of the blood protein profile in B-cell lymphoma patients

| 12.12.2013 | There is a new article in the current issue of Proteomics Clinical Applications on an analysis of the blood protein profile of different B-cell lymphoma using complex antibody microarrays. 200 blood samples from patients with Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL), Chronic Lymphocytic Leukemia (CLL) as well as healthy controls were analysed and compared with each other. The study identified proteins with discriminating power among the different lymphoma types, as well as subgroups within each lymphoma entity.

New article | Prediction of recurrence in bladder cancer

| 08.05.2014 | In a study published in Proteomics we identified proteins with differential abundance in bladder tumours with and without a local recurrence using antibody array technology. Next to interesting differences of the two tumour subtypes from a scientific point of view, we found a protein biomarker signature with high potential for a prognosis. This could enabling urologists in future to adjust the therapy and surveillance scheme accordingly. Further validation studies are ongoing. →Case study report

Tweets

  • 3 days ago

    "We absolutely recommend Sciomics to everyone interested in an antibody array service" -from Prof Gräler -Thank you! https://t.co/RJvdhMZxRa

  • 9 days ago

    Looking forward to the webinar presenting our platform for protein #biomarker identification and verification from… https://t.co/tDgtQvrDKp

  • 13 days ago

    RT @SiFulle: Key characteristics of successful teams are: dependability, structure and clarity, meaning, impact; and most important psychol…

  • 50 days ago

    "Sciomics….a perfect solution for antibody based arrays" – from Dr. Bhavani Kowtharapu. Thank you very much! https://t.co/EjEiX3V0oQ

  • 57 days ago

    "We absolutely recommend Sciomics to everyone interested in an antibody array service" -from Prof Gräler -Thank you! https://t.co/wQH01WsoJw